微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 93.15% | 0.74% | 18.36% | 4/159 | -1.59% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 78.7% | -16.86% | 1.25% | 21/159 | 15.28% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 77.73% | -21.24% | -9.1% | 21/159 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 85.51% | -13.57% | -7.52% | 13/159 | 51.78% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 92.46% | -7.16% | -2.32% | 6/159 | 22.81% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 94.66% | -5.15% | -4.09% | 4/159 | 33.25% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 98.69% | -0.77% | -0.24% | 2/159 | 51.56% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 98.93% | -0.82% | -0.67% | 1/159 | 51.39% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 99.59% | -0.08% | -0.21% | 1/159 | 32.56% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 99.8% | 0.37% | 0.34% | 1/159 | 38.45% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 99.46% | 0.9% | -0.29% | 1/159 | 52.78% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 99.75% | 23.11% | 0.07% | 1/159 | 53.66% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 99.67% | 34.62% | 0.24% | 1/159 | 6.2% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 99.44% | 55.8% | 0.88% | 1/159 | 21.37% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 98.57% | 2% | 21.65% | 1/159 | 54.28% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 81.02% | 133.68% | 9.43% | 25/159 | 55.1% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 74.04% | 2% | 16.01% | 30/159 | 46.78% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 63.82% | 43.88% | 84.08% | 51/159 | 47.23% | 艾力斯 | 98.7% | 行业排名> |
| 2020-12-31 | 34.67% | 2% | -21.84% | 117/159 | -145.9% | 艾力斯 | 99.4% | 行业排名> |
| 2020-06-30 | 44.36% | 2% | 2% | 87/159 | 54.11% | 首药控股 | 99.94% | 行业排名> |